Reason for request
Inclusion
Clinical Benefit
| Substantial |
The actual benefit of PLENADREN is substantial.
|
Clinical Added Value
| minor |
The PLENADREN modified-release dosage form of hydrocortisone is closer to the pharmacokinetic profile of the physiological rhythm of cortisol, without any clinical consequence having been demonstrated. Consequently, PLENADREN provides a minor improvement in actual benefit (IAB IV) in the care of patients with adrenal insufficiency.
|
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
5sz8wpycxS6eHzyd